FdaApplication
ANDA 211020
Identifiers
- fda_app_no: ANDA211020
Properties
| Property | Value |
|---|---|
| applicant_name | GRAVITI PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2019-01-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
2 products